260 related articles for article (PubMed ID: 121803)
1. Multiplicity of liver drug metabolizing enzymes.
Lu AY
Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
[No Abstract] [Full Text] [Related]
2. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
3. Induction of the drug-metabolizing enzymes.
Poland A
IARC Sci Publ; 1982; (39):351-64. PubMed ID: 6818143
[No Abstract] [Full Text] [Related]
4. [The effect of selenium on enzymes metabolizing xenobiotics in rat liver].
Kravchenko LV; Kuz'mina EE; Avren'eva LI; Pozdniakov AL
Vopr Med Khim; 1991; 37(5):73-6. PubMed ID: 1759407
[TBL] [Abstract][Full Text] [Related]
5. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
Cresteil T; Leroux JP
Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
Golan MD; Bücker M; Schmassmann HU; Raphael D; Jung R; Bindel U; Brase HO; Tegtmeyer F; Friedberg T; Lorenz J; Stasiecki P; Oesch F
Drug Metab Dispos; 1980; 8(3):121-6. PubMed ID: 6104571
[No Abstract] [Full Text] [Related]
7. Initial characterization of drug-metabolizing systems in the liver of the Northern pike, Esox lucius.
Balk L; Meijer J; Seidegärd J; Morgenstein R; Depierre JW
Drug Metab Dispos; 1980; 8(2):98-103. PubMed ID: 6103796
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolizing enzyme induction by benzoquinolines, acridine, and quinacrine; tricyclic aromatic molecules containing a single heterocyclic nitrogen.
Le HT; Lamb JG; Franklin MR
J Biochem Toxicol; 1996; 11(6):297-303. PubMed ID: 9176741
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid as it relates to the metabolism of drugs and environmental agents.
Zannoni VG; Susick RL; Smart RC
Curr Concepts Nutr; 1984; 13():21-35. PubMed ID: 6439476
[No Abstract] [Full Text] [Related]
10. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis.
Cresteil T; Mahu JL; Beaune P; Columelli S; Leroux JP
Pediatr Pharmacol (New York); 1981; 1(4):331-40. PubMed ID: 6810295
[TBL] [Abstract][Full Text] [Related]
11. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
12. Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey.
Longo V; Mazzaccaro A; Ventura P; Gervasi PG
Xenobiotica; 1992 Apr; 22(4):427-31. PubMed ID: 1523863
[TBL] [Abstract][Full Text] [Related]
13. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
Orrenius S; Thor H; Jernström B
Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of drug-metabolizing enzymes in humans.
Pacifici GM; Franchi M; Bencini C; Repetti F; Di Lascio N; Muraro GB
Xenobiotica; 1988 Jul; 18(7):849-56. PubMed ID: 3140501
[TBL] [Abstract][Full Text] [Related]
15. [Activity of enzymes of xenobiotic metabolism in the liver of rats after administration of polychlorinated biphenyls].
Tutel'ian VA; Lashneva NV; Sorokovaia GK; Kravchenko LV; Chichilanova GV; Ivanenko GF; Gadzhieva ZM
Gig Sanit; 1990 May; (5):20-3. PubMed ID: 2118877
[No Abstract] [Full Text] [Related]
16. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
Le HT; Franklin MR
Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
[TBL] [Abstract][Full Text] [Related]
17. [Does the cytochrome P-450-dependent system of microsomal monooxygenases protect the body from the toxic effect of xenobiotics?].
Lutz W; Szeszko A; Stankiewicz A
Pol Tyg Lek; 1988 Jun; 43(25):795-8. PubMed ID: 3149404
[No Abstract] [Full Text] [Related]
18. [Xenobiotic-metabolizing enzymes in rat liver and small intestinal mucosa with varying combinations of polyunsaturated omega-6 and omega-3 fatty acids in the diet].
Kravchenko LV; Kuz'mina EE; Avren'eva LI; Kulakova SN; Levachev MM; Tutel'ian VA
Vopr Med Khim; 1992; 38(6):53-6. PubMed ID: 1298135
[TBL] [Abstract][Full Text] [Related]
19. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
Hietanen E; Ahotupa M; Heikelä A; Laitinen M
Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
[TBL] [Abstract][Full Text] [Related]
20. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
Wada O; Yano Y
Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
